SWOT Analysis-Style Panel Discussion – Topics to be Addressed:

Time: 9:30 am
day: Day One


  • Reviewing the inflammasome therapeutics landscape – what have we learnt from recent progress and failures?
  • What are the strengths of inflammasome therapeutics that continue to drive their development in pharma and biotech pipelines?
  • What is the market opportunity and untapped clinical areas versus greatest unmet patient clinical need that can be addressed by emerging inflammasome therapeutics?
  • How have competing drug modalities reached late-stage clinical testing and what are the bottlenecks holding back inflammasome therapeutics from clinical success?